Variant report
Variant | nsv524738 |
---|---|
Chromosome Location | chr17:16861332-16863308 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4985694 | chr17:16861332-16861333 | Weak transcription Transcr. at gene 5' and 3' | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs562560184 | chr17:16861333-16861334 | Weak transcription Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
3 | rs72637383 | chr17:16861359-16861360 | Weak transcription Transcr. at gene 5' and 3' | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs184355600 | chr17:16861392-16861393 | Weak transcription Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
5 | rs142865968 | chr17:16861455-16861456 | Weak transcription Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
6 | rs66479858 | chr17:16861456-16861457 | Weak transcription Transcr. at gene 5' and 3' | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs150627250 | chr17:16861507-16861508 | Weak transcription Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
8 | rs373595382 | chr17:16861570-16861571 | Weak transcription Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
9 | rs530437248 | chr17:16861598-16861599 | Weak transcription Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
10 | rs367770440 | chr17:16861627-16861628 | Weak transcription Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
11 | rs556280574 | chr17:16861644-16861645 | Weak transcription Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
12 | rs34678916 | chr17:16861727-16861728 | Weak transcription Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
13 | rs397857120 | chr17:16861737-16861738 | Weak transcription Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
14 | rs139692173 | chr17:16861739-16861740 | Weak transcription Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
15 | rs372882364 | chr17:16861786-16861787 | Weak transcription Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
16 | rs201756437 | chr17:16861807-16861808 | Enhancers Weak transcription Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
17 | rs115924323 | chr17:16861821-16861822 | Enhancers Weak transcription Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
18 | rs190421862 | chr17:16861844-16861845 | Enhancers Weak transcription Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
19 | rs146882485 | chr17:16861939-16861940 | Enhancers Weak transcription Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
20 | rs372597844 | chr17:16861953-16861954 | Enhancers Weak transcription Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
21 | rs117719990 | chr17:16861969-16861970 | Enhancers Weak transcription Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
22 | rs554771288 | chr17:16862047-16862048 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs377421844 | chr17:16862068-16862069 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs140701752 | chr17:16862075-16862076 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs115393722 | chr17:16862093-16862094 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs376070058 | chr17:16862094-16862095 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs549434102 | chr17:16862179-16862180 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs556115604 | chr17:16862182-16862183 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs4985720 | chr17:16862230-16862231 | Weak transcription Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs181224196 | chr17:16862298-16862299 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs565194352 | chr17:16862375-16862376 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs572502057 | chr17:16862388-16862389 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs541236184 | chr17:16862427-16862428 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs66847673 | chr17:16862449-16862450 | Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs530400202 | chr17:16862451-16862452 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs548682790 | chr17:16862508-16862509 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs117453073 | chr17:16862527-16862528 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs531974062 | chr17:16862528-16862529 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs552156143 | chr17:16862696-16862697 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs138481445 | chr17:16862746-16862747 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs377248483 | chr17:16862747-16862748 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs147037902 | chr17:16862748-16862749 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs35179518 | chr17:16862750-16862751 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs34870066 | chr17:16862792-16862793 | Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs35644895 | chr17:16862854-16862855 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs186690115 | chr17:16862905-16862906 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs73291185 | chr17:16862931-16862932 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs571424371 | chr17:16862932-16862933 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs112379004 | chr17:16863005-16863006 | Weak transcription Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
50 | rs200986872 | chr17:16863016-16863017 | Weak transcription Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Chordoma | 21602918 | CNVD |
Miller-Dieker syndrome | 22283845 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Cancer | 22429812 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Breast cancer | 22028636 | CNVD |
Breast cancer | 20837533 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
colon cancer | 17210682 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Chronic lymphocytic leukemia | 17971485 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16461572 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Moyamoya disease | 22323933 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Colorectal cancer | 21645411 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
HIV/AIDS | 17953491 | CNVD |
HIV/AIDS | 20877625 | CNVD |
Immune disease | 21076436 | CNVD |
Rheumatoid arthritis | 17953491 | CNVD |
Type 1 diabetes | 17953491 | CNVD |
HIV/AIDS | 15637236 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Neurofibromatosis | 18196300 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Breast cancer | 17001317 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Charcot-marie-tooth disease | 16463004 | CNVD |
Osteosarcoma | 22292074 | CNVD |
Breast cancer | 17603634 | CNVD |
Charcot | 16760730 | CNVD |
Mental retardation | 17901693 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
ovarian endometriomas | 16273235 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Gastric cancer | 18160780 | CNVD |
Smith-Magenis syndrome | 18923513 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 22492990 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 18414209 | CNVD |
Developmental delay | 21549014 | CNVD |
Epilepsy | 20970697 | CNVD |
Mental retardation | 18414209 | CNVD |
Mental retardation | 21549014 | CNVD |
Smith-Magenis syndrome | 21981782 | CNVD |
Smith-Magenis syndrome | 20188345 | CNVD |
Smith-Magenis syndrome | 16775514 | CNVD |
Smith-Magenis syndrome | 22585170 | CNVD |
Smith-Magenis syndrome | 22241247 | CNVD |
Autism | 20970697 | CNVD |
Mental retardation | 19951919 | CNVD |
Potocki-Lupski syndrome | 21271655 | CNVD |
Potocki-lupski syndrome | 17357070 | CNVD |
Potocki-lupski syndrome | 20110824 | CNVD |
Potocki-lupski syndrome | 18923514 | CNVD |
Potocki-lupski syndrome | 22241247 | CNVD |
Potocki-lupski syndrome | 20188345 | CNVD |
Schizophrenia | 21399695 | CNVD |
Mental retardation | 16773131 | CNVD |
Adenocarcinoma | 19607727 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Charcot-marie-tooth disease | 22470819 | CNVD |
Neurofibromatosis | 22470819 | CNVD |
Neuropathy | 22470819 | CNVD |
Smith-Magenis syndrome | 18301319 | CNVD |
Smith-Magenis syndrome | 17357070 | CNVD |
Smith-Magenis syndrome | 18469339 | CNVD |
Smith-Magenis syndrome | 22241097 | CNVD |
Smith-Magenis syndrome | 22470819 | CNVD |
Tourette syndrome | 18923514 | CNVD |
Type 1 diabetes | 22470819 | CNVD |
Potocki-lupski syndrome | 18469339 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Neuropathy | 17597781 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 17015230 | CNVD |
Smith-Magenis syndrome | 17597781 | CNVD |
Potocki-lupski syndrome | 18059269 | CNVD |
Potocki-lupski syndrome | 17597781 | CNVD |
Mental retardation | 17847001 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Breast cancer | 20409316 | CNVD |
Breast cancer | 21509527 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Multiple myeloma | 17550852 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:16859200-16862000 | Transcr. at gene 5' and 3' | GM12878-XiMat | blood |
2 | chr17:16861000-16861800 | Weak transcription | Primary B cells from cord blood | blood |
3 | chr17:16861000-16863600 | Weak transcription | Primary B cells from peripheral blood | blood |
4 | chr17:16861800-16862200 | Enhancers | Primary B cells from cord blood | blood |
5 | chr17:16862000-16862400 | Flanking Active TSS | GM12878-XiMat | blood |
6 | chr17:16862200-16871600 | Weak transcription | Primary B cells from cord blood | blood |
7 | chr17:16862400-16863000 | Active TSS | GM12878-XiMat | blood |
8 | chr17:16863000-16866800 | Transcr. at gene 5' and 3' | GM12878-XiMat | blood |